A handful of biotech stocks made an elite list despite being unprofitable. But many show robust sales growth and constructive ...

Tremfya was administered subcutaneously for both induction and maintenance, inducing a clinical response in 65% of moderate ...

ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease New detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug ...

REYKJAVIK, Iceland and PARSIPPANY, NJ, USA I1, 2025 I Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: ...

Wembanyama has deep vein thrombosis in his right shoulder — a serious condition that occurs when a blood clot forms in a vein ...

Teva and Alvotech are introducing Selarsdi at an 85% discount off the reference product Stelara. Selarsdi is available as a subcutaneous injection and for intravenous infusion.

In a sense, every investor is a growth investor. Even those who are primarily seeking income enjoy when the stocks they buy ...

Oxidative stress, caused by an imbalance between reactive oxygen species (ROS) and antioxidant defenses, plays a central role ...

Modern life makes us tired, right? But research from societies in Africa and South America suggests people in the ancient ...